Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Agilent Technologies (A) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareDiagnostics & ResearchA

Latest price · Nov 20, 2026 $171.33 -2.3% on the day · +19.0% over 12 months 52-week range $109.61 – $181.48
Get A alerts
Open-market purchases0 insidersno buys · last 12 months
Insiders selling3last 12 months
Reported sales$1.3M2 of 6 recent sales pre-planned (10b5-1)
In 15 seconds

No open-market insider buying in the last 12 months. Selling alone is common (taxes, diversification, pre-planned 10b5-1 sales) and isn't treated as a signal here.

Label: Heavy selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Nov 25, 2026 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Sale Mikael Dolsten, Director sold 634 shares at $151.38 ($96K).

Trade date
Sep 4, 2026
Disclosed to the SEC
Sep 9, 2026
Type
Sale (code S)

Read the original SEC filing ↗All A insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

A insider transactions (Form 4)

Open-market purchases and sales. 91 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
Sep 9SEC Mikael DolstenDirector Sell 6344,924 held (−11%) $151.38 $96K +13.2% —
Jun 2SEC Mikael DolstenDirector Sell 1,6005,548 held (−22%) $135.42 $217K +26.5% —
Dec 3SEC Mikael DolstenDirector Sell 2,6004,973 held (−34%) $149.81 $390K +14.4% —
Dec 1SEC Rodney GonsalvesV.P., Corporate Controller Sell 3,00031,846 held (−9%) $154.99 $465K +10.5% —
Nov 20SEC Padraig McDonnellCEO, President Sell Plan 91132,058 held (−3%) $143.24 $130K +19.6% —
Nov 14SEC Padraig McDonnellCEO, President Sell Plan 12,49033,448 held (−27%) $150.00 $1.9M +14.2% —
Historical context

Similar past setups: not applicable. A has had no open-market insider purchases in the last 12 months, so there's no buying setup to compare with history. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with A in the Research Lab

A has no open-market insider buys in the last 12 months. Try the tools with any setup.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

A closeInsider buyInsider sale
100125150175200DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2025-11-24EEarnings release filed 2026-02-25EEarnings release filed 2026-05-27EEarnings release filed 2026-08-26Sold $95,972 on 2026-09-04 · Mikael DolstenSold $216,672 on 2026-05-29 · Mikael DolstenSold $389,511 on 2025-12-01 · Mikael DolstenSold $464,956 on 2025-11-26 · Rodney Gonsalves
Bought, 12 months$0
Sold, 12 months$1.3M
Insiders buying0
Insiders selling3

Agilent Technologies insider trading at a glance (Nov 20, 2026): in the past 12 months, 0 insiders bought $0 and 3 sold $1.3M of A stock on the open market; P/E 34.1 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

A insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q4 2025: $2.9M sold (4 trades)Q4 2025Q1 2026Q2 2026: $217K sold (1 trades)Q2 2026Q3 2026: $96K sold (1 trades)Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0$96K1
Q2 2026—0$217K1
Q1 2026—0—0
Q4 2025—0$2.9M4

Valuation, profit and volume

P/E (trailing)34.1Sector median 25.0
Market value$48.72BDiagnostics & Research
Profit margin19.5%Revenue growth +8.1%
Volume vs. 50-day0.8×Last 5 sessions

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 0 Agilent Technologies insiders reported open-market purchases totaling $0, while 3 insiders reported sales totaling $1.3M. 2 of 6 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

A earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Aug 26, 2026 +4.1% None +1.9%S&P +0.7% +9.6%
May 27, 2026 +3.2% None +17.6%S&P +0.5% +0.5%
Feb 25, 2026 -2.4% None -2.8%S&P +0.3% -8.9%
Nov 24, 2025 +2.5% Sold $2.0M +3.9%S&P +2.4% -12.0%
Aug 27, 2025 +3.7% None +5.6%S&P +0.6% -1.3%
May 28, 2025 -3.7% None +1.8%S&P -0.2% +5.2%
Feb 26, 2025 -6.6% None -5.3%S&P -1.5% -8.2%
Nov 25, 2024 -4.1% None +0.4%S&P +0.9% +1.1%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

A short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 64% of volume sold short2026-08-27: 58% of volume sold short2026-08-28: 46% of volume sold short2026-08-31: 42% of volume sold short2026-09-01: 60% of volume sold short2026-09-02: 55% of volume sold short2026-09-03: 47% of volume sold short2026-09-04: 51% of volume sold short2026-09-08: 65% of volume sold short2026-09-09: 54% of volume sold short2026-09-10: 60% of volume sold short2026-09-11: 44% of volume sold short2026-09-14: 60% of volume sold short2026-09-15: 63% of volume sold short2026-09-16: 73% of volume sold short2026-09-17: 77% of volume sold short2026-09-18: 69% of volume sold short2026-09-21: 47% of volume sold short2026-09-22: 46% of volume sold short2026-09-23: 28% of volume sold short2026-09-24: 51% of volume sold short2026-09-25: 36% of volume sold short2026-09-28: 43% of volume sold short2026-09-29: 50% of volume sold short2026-09-30: 38% of volume sold short2026-10-01: 52% of volume sold short2026-10-02: 38% of volume sold short2026-10-05: 31% of volume sold short2026-10-06: 47% of volume sold short2026-10-07: 49% of volume sold short2026-10-08: 31% of volume sold short2026-10-09: 44% of volume sold short2026-10-12: 43% of volume sold short2026-10-13: 45% of volume sold short2026-10-14: 60% of volume sold short2026-10-15: 57% of volume sold short2026-10-16: 60% of volume sold short2026-10-19: 53% of volume sold short2026-10-20: 43% of volume sold short2026-10-21: 67% of volume sold short2026-10-22: 49% of volume sold short2026-10-23: 43% of volume sold short2026-10-26: 52% of volume sold short2026-10-27: 49% of volume sold short2026-10-28: 54% of volume sold short2026-10-29: 51% of volume sold short2026-10-30: 43% of volume sold short2026-11-02: 54% of volume sold short2026-11-03: 47% of volume sold short2026-11-04: 56% of volume sold short2026-11-05: 51% of volume sold short2026-11-06: 41% of volume sold short2026-11-09: 51% of volume sold short2026-11-10: 53% of volume sold short2026-11-11: 42% of volume sold short2026-11-12: 48% of volume sold short2026-11-13: 57% of volume sold short2026-11-16: 54% of volume sold short2026-11-17: 58% of volume sold short2026-11-18: 75% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 75%20-day average: 51%Prior 2 months: 51%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

Members of Congress who traded A

From STOCK Act disclosures. Reported up to 45 days after the trade, in dollar ranges.

All Congress trades →
MemberTradeTradedReportedSince trade
Thomas H TubervilleSenate Sold $1,001 - $15,000 May 3, 2024Aug 5, 2026 +25.2%

Insiders at Agilent Technologies

InsiderBoughtSoldLast filingPast buys beat S&PScore
Padraig McDonnellCEO, President — $2.0M Nov 19, 2026 — —
Mikael DolstenDirector — $702K Sep 9, 2026 — —
Rodney GonsalvesV.P., Corporate Controller — $465K Dec 1, 2025 — —
Simon MayPresident — — Nov 19, 2026 — —
Jonah Prevost KirkwoodPresident — — Nov 19, 2026 — —
Angelica RiemannPresident — — Nov 19, 2026 — —
Adam Stewart ElinoffCFO, President — — Nov 19, 2026 — —
Jianmiao Mike ZhangPresident — — Nov 19, 2026 — —
Meghan HensonPresident — — Nov 19, 2026 — —
Glenn S. BoehnleinDirector — — Sep 10, 2026 — —
Michael Steven BucknerPresident — — May 21, 2026 — —
Mala AnandDirector — — Mar 23, 2026 — —
Judy L. BrownDirector — — Mar 23, 2026 — —
Boon Hwee KohDirector — — Mar 23, 2026 — —
Daniel K. PodolskyDirector — — Mar 23, 2026 — —
Dow R. WilsonDirector — — Mar 23, 2026 — —
Pascal SoriotDirector — — Mar 23, 2026 — —
George A. ScangosDirector — — Mar 23, 2026 — —
Otis W. BrawleyDirector — — Mar 23, 2026 0 of 1 —
Sue H. RatajDirector — — Mar 23, 2026 — —
Bret DimarcoPresident — — Dec 1, 2025 — —

Board links: companies that share insiders with A

Directors and executives who filed Form 4s for A and another company in the last 12 months.

See the map →
  • DXCMDexcom Glenn S. Boehnlein Director here · Director at DXCM · latest filing Sep 10, 2026
  • INCYIncyte Otis W. Brawley Director here · Director at INCY · latest filing Jun 10, 2026

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

A stock: common questions

Are Agilent Technologies insiders buying A stock?

No. No Agilent Technologies insider reported an open-market purchase of A in the past 12 months.

Are Agilent Technologies insiders selling A stock?

3 insiders reported sales worth $1.3M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is A's P/E ratio?

A trades at about 34.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is A's 52-week range?

Over the past year A has traded between $109.61 and $181.48. It last closed at $171.33 on Nov 20, 2026.